首页> 外国专利> HUMAN LIFE EXTENSION THERAPY THROUGH MOLECULAR, CELLULAR AND SUBCELLULAR MANAGEMENT OF BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OF OTHER ORGANELLE PROCESSES ASSOCIATED WITH THE ADVENT OF DISEASE AND/OR AGING

HUMAN LIFE EXTENSION THERAPY THROUGH MOLECULAR, CELLULAR AND SUBCELLULAR MANAGEMENT OF BIOCHEMICAL REQUIREMENTS OF MITOCHONDRIA AND OF OTHER ORGANELLE PROCESSES ASSOCIATED WITH THE ADVENT OF DISEASE AND/OR AGING

机译:通过线粒体,线粒体和亚细胞的线粒体生物化学要求以及与疾病和/或衰老相关的其他器官过程的生命扩展治疗

摘要

This invention provides compositions, systems and methods that improve and/or optimize the health and performance of animals, especially mammals including humans, canines, equines, felines, etc. Key aspects of the principle invention and its parts include the monitoring, management and modulation of the body's natural cannabinoid systems through its native mechanisms thereby optimizing its processes by supplementation with endogenously occurring components and/or by administering synthetic compounds. The invention selects from multiple available resources to modify and/or rebalance an individual system or it may be applied across interconnected systems. The encompassing system that is intricately involved in the operations and intensities, e.g., the balancing of most other systems of our bodies, relates to cannabinoid compounds and their receptors. The cannabinoid pathways can be coordinated in rebalancing multiple and various metabolic pathways. Compositions comprising compounds that slow degradation of native endocannabinoids, that stimulate their production and/or compounds that act on cannabinoid receptors within the body are featured in systems and methods of this invention. The activated and rebalanced cannabinoid systems then become adept at modulating and the rebalancing of the numerous systems in which they participate to improve one or more systems including, but not limited to: normal and/or abnormal stresses of life, environmental influences, genomic or epigenomic irregularities and/or normal or accentuated processes of aging. Specifically targeted systems may include, but are not limited to, those involved in: cellular and/or mitochondrial metabolism, corticosteroid synthesis and effects, appetite, allergy and immunity, sleep and waking, etc. Practicing the invention selects from multiple approaches that may be used independently or in concert to compensate for a variety of concerns. Supplementing dietary intake to rebalance metabolism and/or its metabolic responses—including immunogenic or allergic responses to pathogenic and/or environmental stresses is one focus. Additional features of the invention may include: compensating for failing or decreasing androgen hormone levels as a human continues to age, rebalancing the organism's metabolism through providing mitochondrial supplements, and serially revisiting effects of the early stages of treatment to redirect or improve activity of all aspects of life and metabolism.
机译:本发明提供了改善和/或优化动物,特别是哺乳动物,包括人,犬,马,猫等的健康和性能的组合物,系统和方法。原理发明及其部分的关键方面包括监测,管理和调节通过其天然机制改善人体的天然大麻素系统,从而通过补充内源性成分和/或施用合成化合物来优化其过程。本发明从多个可用资源中进行选择以修改和/或重新平衡单个系统,或者可以跨互连的系统应用它。涉及操作和强度的复杂系统,例如人体大多数其他系统的平衡,涉及大麻素化合物及其受体。大麻素途径可以协调多种代谢途径的平衡。包含减缓天然内源性大麻素降解,刺激其产生的化合物和/或作用于体内大麻素受体的化合物的组合物是本发明的系统和方法的特征。然后,激活和重新平衡的大麻素系统会熟练地调节和参与众多系统的重新平衡,以使它们参与其中,以改善一个或多个系统,包括但不限于:正常和/或异常的生活压力,环境影响,基因组学或表观基因组学不规则和/或正常或加剧的老化过程。专门针对的系统可以包括但不限于涉及以下系统:细胞和/或线粒体代谢,皮质类固醇合成和作用,食欲,过敏和免疫力,睡眠和苏醒等。实施本发明选自多种方法,可以是独立使用或共同使用以补偿各种问题。补充饮食摄入以重新平衡代谢和/或其代谢反应(包括对病原和/或环境压力的免疫原性或过敏反应)是一个重点。本发明的其他特征可以包括:随着人类的持续衰老补偿雄激素水平的下降或降低;通过提供线粒体补充剂来平衡生物体的新陈代谢;以及顺序地重新审视治疗早期的作用以重定向或改善各个方面的活动。生活和新陈代谢。

著录项

  • 公开/公告号US2019030044A1

    专利类型

  • 公开/公告日2019-01-31

    原文格式PDF

  • 申请/专利权人 RICHARD POSTREL;

    申请/专利号US201815952226

  • 发明设计人 RICHARD POSTREL;

    申请日2018-04-12

  • 分类号A61K31/568;A61K38/16;A61K31/352;A61K31/05;A61K45/06;A61K47/55;

  • 国家 US

  • 入库时间 2022-08-21 12:05:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号